Brescu®

Abemaciclib

Product Information

  • Proprietary Name: Brescu®
  • Generic Name: Abemaciclib
  • Dosage Form: Film-coated Tablet
  • Strengths: 50 mg, 150 mg
  • Indications: Breast Cancer
Download Leaflet

Oncology

Brescu®

Abemaciclib is indicated for the treatment of patients with breast cancer.

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.